VC-backed SpineGuard to list on Alternext

SpineGuard has already raised in excess of €15m from several backers in the past four years. Omnes (then Crédit Agricole Private Equity) and Innoven Partenaires co-led an $11m investment in SpineGuard alongside A Plus Finance in 2009. Later that same year, Delta Partners provided SpineGuard with a further €2.75m. The existing backers injected a further $6.2m in September 2011.

The offer period will run from 11 April to 22 April and the business will first list on 23 April. SpineGuard will issue more than 1.1 million new shares, initially priced in the €7.29-8.91 range. Based on a median share price, SpineGuard could raise up to €10.35m.

A Plus, Omnes, Delta and IPSA have committed to invest €1.8m as part of the capital increase. The investors are subject to a six-month lock-up period.

Founded in 2009, SpineGuard operates as a provider of spinal screw placement devices designed to improve safety for spine surgery. Based in St Mandé, France, the firm has an additional office in San Francisco.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Exits
• Expansion
• Healthcare
• France
• Omnes Capital
• IPO